Type I Interferon Signaling Contributes to Chronic Inflammation in a Murine Model of Silicosis
Author(s) -
Giordano Giulia,
Sybille van den Brûle,
Sandra Lo Re,
Perrine Triqueneaux,
Francine Uwambayinema,
Yousof Yakoub,
Isabelle Couillin,
Bernhard Ryffel,
Thomas Michiels,
JeanChristophe Renauld,
Dominique Lison,
François Huaux
Publication year - 2010
Publication title -
toxicological sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.352
H-Index - 183
eISSN - 1096-6080
pISSN - 1096-0929
DOI - 10.1093/toxsci/kfq158
Subject(s) - silicosis , inflammation , cd11c , lung , fibrosis , chemokine , immunology , interferon , pulmonary fibrosis , downregulation and upregulation , ccl2 , chemistry , medicine , pathology , biochemistry , gene , phenotype
Lung disorders induced by inhaled inorganic particles such as crystalline silica are characterized by chronic inflammation and pulmonary fibrosis. Here, we demonstrate the importance of type I interferon (IFN) in the development of crystalline silica-induced lung inflammation in mice, revealing that viruses and inorganic particles share similar signaling pathways. We found that instillation of silica is followed by the upregulation of IFN-beta and IRF-7 and that granulocytes (GR1(+)) and macrophages/dendritic cells (CD11c(+)) are major producers of type I IFN in response to silica. Two months after silica administration, both IFNAR- and IRF-7-deficient mice produced significantly less pulmonary inflammation and chemokines (KC and CCL2) than competent mice but developed similar lung fibrosis. Our data indicate that type I IFN contributes to the chronic lung inflammation that accompanies silica exposure in mice. Type I IFN is, however, dispensable in the development of silica-induced acute lung inflammation and pulmonary fibrosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom